Clinical evidence indicates that GLP-1s may be associated with sinus and ear conditions, such as sinusitis, nasal congestion, and increased facial pressure due to inflammation of the nasal passages ...
One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked. This makes breathing in through your nostrils frustrating – if not ...
When you’re getting ready for a trip, you have to plan for plenty of things. If you’re living with nasal polyps, it’s important to take certain factors into consideration, so you can prevent ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery ...
How to stop snoring: Experts suggest maintaining an optimum body weight helps reduce airway narrowing and can significantly lessen snoring episodes at night (Image: Canva) Blocked nose often leads to ...
The chronic rhinosinusitis with nasal polyps market growth is being driven by rising disease prevalence, greater awareness, and improved diagnostic rates. Advancements in biologic therapies are ...
For months, colleagues kept asking university lecturer Alison Cavanagh whether she had a cold because her nose was constantly blocked.
Detailed price information for Upstream Bio Inc (UPB-Q) from The Globe and Mail including charting and trades.
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) with a ...
Dupilumab (Dupixent) is available on the NHS. It is a possible treatment for severe chronic rhinosinusitis with nasal polyps in adults if: it is used alongside an intranasal corticosteroid, and the ...
The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending dupilumab as an add-on treatment to intranasal corticosteroids for adults with severe ...
U.S. veterans who served in Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) face an increased risk of developing several chronic respiratory conditions, according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results